Biomedicines — Editors

Journal Contact

Biomedicines Editorial Office
MDPI AG, Klybeckstrasse 64, 4057 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Section Editorial Boards

Tumor Immunology and Immunotherapy

Editorial Office

Prof. Dr. Kenneth Cornetta
Department of Medical and Molecular Genetics, Indiana University School of Medicine, USA
Interests: gene therapy; lentiviral vectors; retroviral vectors; safety of gene therapy; vector production and certification

Assistant Managing Editor
Ms. Lynn Huang
MDPI Wuhan Office, No.6 Jingan Road, 5.5 Creative Industry Park, Floor 25th. 430064 Wuhan, Hubei Province, China
Tel. +86 27 8780 8658; Fax: +86 27 8761 2588

Production Editor
Dr. Martyn Rittman
MDPI AG, Klybeckstrasse 64, CH-4057 Basel, Switzerland

Editorial Board

Prof. Dr. Kari Airenne
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland
Interests: gene delivery; viral vectors; vector production; transduction optimization; gene therapy; therapeutic angiogenesis; baculovirus technology; protein production in insect and mammalian cells; avidin-biotin technology

Prof. Dr. Tony Bjourson
Biomedical Sciences Research Institute, University of Ulster, Coleraine Campus, Cromore Road, Coleraine, Northern Ireland, UK
Interests: invasion and metastasis associated biomarkers; Rheumatoid arthritis; genomic; transcriptomic (microRNA/mRNA); methylation status & proteomic signatures associated research

Dr. Scott W. Blume
Department of Medicine, Division of Hematology/Oncology, and Comprehensive Cancer Center, University of Alabama at Birmingham, 845 19th Street South, Bevill Biomedical Research Bldg. Room 765, Birmingham, AL 35294, USA
Interests: specific regulation of gene expression at the transnational (RNA to protein) level; sequence-specific RNA-binding proteins; development of therapeutic strategies to modulate translation; oncogenes; small molecule and peptide-based interventions; human breast carcinoma; mechanisms of tumor cell death

Dr. Vincenzo Cerullo
1 ImmunoViroTherapy Lab (IVTLab), Helsinki, Finland
2 Centre for Drug Research (CDR) and Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
Tel. +358 29 4159328
Interests: gene therapy; cancer gene therapy; immunotherapy; immunity; innate immunity; immunovirotherapy; oncolytic viruses; adenovirus; vaccinia virus
Contribution: Special Issue: Gene Therapy Used in Cancer Treatment

Dr. Dimiter S. Dimitrov
National Cancer Institute Building 567, Room 152, Frederick, MD 21702, USA
Interests: therapeutic antibodies; human antibodies and their interactions; vaccine immunogens; molecular engineering; screening and sequencing methodologies; therapeutic proteins; cancer; infectious diseases

Dr. Bo Feng
School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, China
Interests: induced pluripotent stem cells; embryonic stem cells; neural stem cells; reprogramming; directed differentiation; regenerative medicine
Contribution: Special Issue: Human Pluripotent Stem Cells for Therapy

Prof. Dr. David T. Harris
Department of Immunobiology, Arizona Health Sciences Centre, University of Arizona, Room 6122, PO Box 245221, Tucson, AZ 85721, USA
Tel. +1 520 626 5127; Fax: +1 520 626 2100
Interests: stem cells; regenerative medicine; tissue engineering; cancer; umbilical cord blood and tissue; adipose-derived stem cells; aging

Prof. Dr. Mitchell Ho
National Cancer Institute, Building 37, Room 5002C, 37 Convent Drive, MSC 4264 Bethesda, MD 20892-4264, USA
Tel. +1 301 451 8727; Fax: +1 301 480 4667
Interests: cancer immunotherapy; antibody engineering; therapeutic antibodies; molecular targets; human monoclonal antibodies; single-domain antibodies; phage display; mammalian cell display; cancer therapeutic targets; tumor spheroid models; liver cancer; hepatocellular carcinoma; mesothelioma

Prof. Dr. Rudolf Jaenisch
Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA
Interests: embryonic stem cells and the control of self-renewal; nuclear cloning; reprogramming of the genome; In vitro reprogramming of somatic cells

Prof. Dr. David R. Janero
Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, 360 Huntington Avenue, 116 Mugar Hall, Boston, MA 02115-5000, USA
Tel. +1 617 373 2208
Interests: enzymology; receptor pharmacology; drug discovery and development; drug targets; cell signaling; structural biology; proteomics; metabolomics; disease models and mechanisms; drug mechanisms

Prof. Dr. John M. Kirkwood
Usher Professor of Medicine, Dermatology and Translational Science Director, Melanoma and Skin Cancer Program University of Pittsburgh Cancer, Institute Laboratory Suite L1.32c, 5117 Centre Avenue, Pittsburgh PA 15213-1863, USA
Interests: melanoma; immunotherapy; T cells; vaccines; immunomodulators; CTLA4 blocking antibodies; interferon alfa-2; cytokines

Dr. Guido Kroemer
Team 11, Centre de Recherche des Cordeliers, 17 rue de l'Ecole de Médecine, 75006 Paris, France
Tel. +33 1 42116046; Fax: +33 1 42116047
Interests: apoptosis; autophagy; necrosis; tumor immunology

Prof. Dr. Margot Mayer-Pröschel
Department of Biomedical Genetics (BMG), University of Rochester, Box 633, 601 Elmwood Ave., Rochester, NY 14642, USA
Interests: impact of nutritional deficiencies on CNS development; glial progenitor biology; cell therapies for CNS diseases; astrocytic dysfunctions; neural inflammation; redox regulation in development and cancer; human herpesvius 6 infections in the brain and impact on repair

Prof. Dr. Ricardo E. Pérez-Tomás
Department of Pathology and Experimental Therapy, Faculty of Medicine, University of Barcelona, Campus de Bellvitge., Lab.5101 C./ Feixa Llarga s/n E- 08907, Hospitalet de Llobregat, Barcelona, Spain
Tel. +34 93 4024288; Fax: +34 93 4024249
Interests: new molecules for cancer chemotherapy; apoptosis; signal transduction for cancer chemotherapy

Dr. Giulia Ricci
Department of Experimental Medicine, Second University of Naples, Naples, Italy.
Interests: growth factors, reproductive biology, embryonic development, testicular germ cell tumours
Contribution: Special Issue: New aspects of the Hepatocyte Growth Factor/c-Met System

Prof. Dr. Caroline Springer
Gene and Oncogene Targeting, The Institute of Cancer Research, Division of Cancer Therapeutics, Cancer Research UK Cancer Therapeutics Unit, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK
Tel. +44 20 8722 4214/ +44 20 7153 5013; Fax: +44 20 8722 4046
Interests: gene therapy; oncolytic viruses; gene delivery; gene-directed enzyme prodrug therapy (GDEPT); cancer therapeutics

Dr. Michael Steinitz
The Department of Pathology, The Hebrew University-Hadassah Medical School, POB 12272, Jerusalem 91120, Israel
Tel. +972 2 6758204; Fax: +972 2 6784010
Interests: Human monoclonal antibodies; Epstein-Barr virus; Autoimmune antibodies; Tissue culture; Human cells in vitro; ELISA

Prof. Dr. Ed Wu
Department of Electrical and Electronic Engineering The University of Hong Kong Pokfulam, Hong Kong, China
Tel. +852 2859 7096; Fax: +852 2559 8738
Interests: biomedical imaging; MRI; brain imaging; heart imaging

Prof. Dr. Florian M. Wurm
Swiss Federal Institute of Technology Lausanne, 1015 Lausanne, Switzerland
Tel. +41 21 693 6145
Interests: gene transfer; protein production/manufacturing from cultivated mammalian cells, including regulatory issues, process development; innovative bioreactors for mammalian cells; suspension culture; CHO cells; large scale manufacturing - CHO; orbital shaking; optimizing mammalian cell culture processes; transient gene expression

Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert